| 000 | 01500 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513155228.0 | ||
| 264 | 0 | _c19990127 | |
| 008 | 199901s 0 0 eng d | ||
| 022 | _a1397-002X | ||
| 024 | 7 |
_a10.1111/j.1399-3011.1998.tb01242.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarbouche, R | |
| 245 | 0 | 0 |
_aProperties of HIV envelope expressed in the presence of SPC3, an Env-derived peptide drug under phase II clinical trials. _h[electronic resource] |
| 260 |
_bThe journal of peptide research : official journal of the American Peptide Society _cOct 1998 |
||
| 300 |
_a283-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAIDS Vaccines _xchemistry |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
| 650 | 0 | 4 |
_aHIV Envelope Protein gp120 _xchemistry |
| 650 | 0 | 4 |
_aHIV Infections _xprevention & control |
| 650 | 0 | 4 |
_aHIV-1 _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPeptide Fragments _xchemistry |
| 650 | 0 | 4 | _aProtein Conformation |
| 650 | 0 | 4 |
_aReceptors, HIV _xantagonists & inhibitors |
| 700 | 1 | _aFenouillet, E | |
| 700 | 1 | _aPapandréou, M J | |
| 700 | 1 | _aKiény, M P | |
| 700 | 1 | _aSabatier, J M | |
| 773 | 0 |
_tThe journal of peptide research : official journal of the American Peptide Society _gvol. 52 _gno. 4 _gp. 283-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1399-3011.1998.tb01242.x _zAvailable from publisher's website |
| 999 |
_c9796406 _d9796406 |
||